Annual Drug Patent Expirations for SPRYCEL Sprycel is a drug marketed by Bristol Myers Squibb and is included in one NDA. It is available from one supplier. There are five…
The post New patent expiration for Bristol Myers drug SPRYCEL appeared first on…
New patent expiration for Bristol Myers drug SPRYCEL Read Post »
Annual Drug Patent Expirations for CAMPTOSAR Camptosar is a drug marketed by Pfizer Inc and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent expiration for Pfizer Inc drug CAMPTOSAR appeared first on…
New patent expiration for Pfizer Inc drug CAMPTOSAR Read Post »
Annual Drug Patent Expirations for METADATE+CD Metadate Cd is a drug marketed by Lannett Co Inc and is included in one NDA. It is available from one supplier. There is…
The post New patent expiration for Lannett Co drug METADATE CD appeared first on Dr…
New patent expiration for Lannett Co drug METADATE CD Read Post »
Annual Drug Patent Expirations for LONHALA+MAGNAIR+KIT Lonhala Magnair Kit is a drug marketed by Sunovion Resp and is included in one NDA. It is available from two suppliers. There are…
The post New patent expiration for Sunovion Resp drug LONHALA MAGN…
New patent expiration for Sunovion Resp drug LONHALA MAGNAIR KIT Read Post »
Annual Drug Patent Expirations for CIALIS Cialis is a drug marketed by Lilly and is included in one NDA. It is available from seven suppliers. There is one patent protecting…
The post New patent expiration for LILLY drug CIALIS appeared first on DrugPa…
Annual Drug Patent Expirations for TYZEKA Tyzeka is a drug marketed by Novartis and is included in two NDAs. There are three patents protecting this drug. This drug has fifty-five…
The post New patent expiration for Novartis drug TYZEKA appeared first …
Annual Drug Patent Expirations for THALOMID Thalomid is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. There are nine patents protecting…
The post New patent expiration for Celgene drug THALOMID appeared first…
Annual Drug Patent Expirations for POMALYST Pomalyst is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. There are eleven patents protecting…
The post New patent expiration for Celgene drug POMALYST appeared fir…
Annual Drug Patent Expirations for REVLIMID Revlimid is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. There are twenty patents protecting…
The post New patent expiration for Celgene drug REVLIMID appeared fir…
AVANDIA (rosiglitazone maleate) Sb pharmco Patent: 7,358,366 Expiration: Oct 19, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Drug…
Drug Patent Expirations for the Week of October 18, 2020 Read Post »